A retrospective analysis sought to determine the association between myeloproliferative neoplasms, MPN-directed therapy, and development of splanchnic vein thrombosis.
Although some red blood cell-related parameters used in the diagnosis of PV may be misleading in the setting of iron-deficiency, RBC count may be an effective biomarker for PV when combined with ESR.
This nonrandomized study enrolled more than 100 patients with essential thrombocythemia or polycythemia vera resistant to or intolerant of hydroxyurea to determine if interferon alfa-2a is effective in these patients.
This meta-analysis evaluated the effects of different therapeutic approaches on the live birth rate and maternal outcomes of pregnant women with MPNs.
Identifying progressive anemia and thrombocytopenia in patients with PV or ET may be predictive of MPN progression to secondary myelofibrosis.